These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15577250)

  • 1. Synthesis and biological evaluation of peptide mimics derived from first extracellular loop of CCR5 toward HIV-1.
    Ikeda K; Ishii Y; Konishi K; Sato M; Tanaka K
    Chem Pharm Bull (Tokyo); 2004 Dec; 52(12):1479-82. PubMed ID: 15577250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of peptides mimicking chemokine receptor CCR5 and their inhibitory effects against HIV-1 infection.
    Konishi K; Ikeda K; Achiwa K; Hoshino H; Tanaka K
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):308-9. PubMed ID: 10705530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of LC5, the CCR5- derived peptide for HIV-1 inhibition.
    Miyamoto K; Togiya K; Kitahara R; Akasaka K; Kuroda Y
    J Pept Sci; 2010 Apr; 16(4):165-70. PubMed ID: 20196122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
    Imai M; Baranyi L; Okada N; Okada H
    Biochem Biophys Res Commun; 2007 Feb; 353(4):851-6. PubMed ID: 17210123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the L-enantiomer of 4'-C-ethynyl-2'-deoxycytidine.
    Kohgo S; Mitsuya H; Ohrui H
    Biosci Biotechnol Biochem; 2001 Aug; 65(8):1879-82. PubMed ID: 11577734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some peptides corresponding to the active region of RANTES for chemotaxis and evaluation of their anti-human immunodeficiency virus-1 activity.
    Nishiyama Y; Murakami T; Kurita K; Yamamoto N
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2125-8. PubMed ID: 9433785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller.
    Chevigne A; Delhalle S; Counson M; Beaupain N; Rybicki A; Verschueren C; Staub T; Schmit JC; Seguin-Devaux C; Deroo S
    AIDS; 2016 Jan; 30(3):377-82. PubMed ID: 26760231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CCR5, a new target of anti-HIV drugs].
    Han YX; Jiang JD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):635-9. PubMed ID: 14650176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of anti-HIV type 1 activity of a small CCR5 peptide antagonist.
    Wang FY; He SY; Zhang ZJ; He LF; Chen XW; Teng T
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1111-5. PubMed ID: 21375388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of anti-HIV-1 and anti-HSV-1 activities of 4H-[1,2,4]-triazolo[1,5-a]pyrimidin-5-one derivatives.
    Abdel-Hafez AA; Elsherief HA; Jo M; Kurokawa M; Shiraki K; Kawahata T; Otake T; Nakamura N; Hattori M
    Arzneimittelforschung; 2002; 52(11):833-9. PubMed ID: 12489255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-HIV activity of C4-modified pyrimidine nucleosides.
    Wallis MP; Mahmood N; Fraser W
    Farmaco; 1999; 54(1-2):83-9. PubMed ID: 10321033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists.
    Hu S; Wang Z; Hou T; Ma X; Li J; Liu T; Xie X; Hu Y
    Bioorg Med Chem; 2015 Mar; 23(5):1157-68. PubMed ID: 25638498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5.
    Secchi M; Vassena L; Morin S; Schols D; Vangelista L
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6215-23. PubMed ID: 25114130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives.
    Imamura S; Ishihara Y; Hattori T; Kurasawa O; Matsushita Y; Sugihara Y; Kanzaki N; Iizawa Y; Baba M; Hashiguchi S
    Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):63-73. PubMed ID: 14709870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II.
    Luo Z; Fan X; Zhou N; Hiraoka M; Luo J; Kaji H; Huang Z
    Biochemistry; 2000 Nov; 39(44):13545-50. PubMed ID: 11063591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells.
    Pollicita M; Ruff MR; Pert CB; Polianova MT; Schols D; Ranazzi A; Perno CF; Aquaro S
    Antivir Chem Chemother; 2007; 18(5):285-95. PubMed ID: 18046961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides.
    Secchi M; Longhi R; Vassena L; Sironi F; Grzesiek S; Lusso P; Vangelista L
    Chem Biol; 2012 Dec; 19(12):1579-88. PubMed ID: 23261601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulation.
    Dettin M; Zanchetta M; Pasquato A; Borrello M; Piatier-Tonneau D; Di Bello C; De Rossi A
    Biochem Biophys Res Commun; 2003 Aug; 307(3):640-6. PubMed ID: 12893271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 antagonists as anti-HIV-1 agents. Part 2: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N'-diphenylureas.
    Imamura S; Kurasawa O; Nara Y; Ichikawa T; Nishikawa Y; Iida T; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
    Bioorg Med Chem; 2004 May; 12(9):2295-306. PubMed ID: 15080927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
    Kazmierski WM; Kenakin TP; Gudmundsson KS
    Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.